Search results

Hettich AG, based in Bäch, Switzerland, has supplied laboratory equipment since 1977. We develop and distribute Hettich instruments and represent Memmert, Helmer, B Medical Systems and delta T, supporting life science customers with expertise, reliability and local service.

CALDRE is a Switzerland based biotech spin-out focussed to revolutionize the way cholestatic-and fibrotic diseases are treated. We develop precise, liver-directed GalNAc-siRNAs to restore bile flow and prevent fibrosis - placing CALDRE in the fast-growing RNA-therapeutics segment of biotech.

RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

Nxera Pharma is a tech-driven biopharma company focused on specialty medicines for unmet needs in Japan and globally. With 30+ active programs in neurology, GI, immunology, metabolic, and rare diseases, Nxera employs 350+ people across Japan, the UK, Switzerland, and South Korea.

Philip Morris International (PMI) is a leading international tobacco company with the objective to replace cigarettes with smoke-free products. The goal is to offer adult smokers, who would otherwise continue to smoke, better alternatives that are scientifically substantiated.

Juvion develops advanced therapeutics aimed at preserving neuron-muscle connectivity, tackling immobility and sarcopenia to extend healthspan.

NanThermix SA is a pioneer in nanoscale temperature control within living cells for applications across life sciences, from academic research to biomedical fields, based on a novel technollogy of all-optical nanodiamond heater / thermometer.

HekeTiss, a UNIGE/HUG spin-off, enhances lives by pioneering cell-therapy treatments for ulcerative skin conditions. Innovating for a healthier tomorrow.

We build true longevity by turning proven drugs into patient-friendly, affordable prescription medicines. With our ORASMART® platform technology, we scale from an initial focus on two indications to more than 30 longevity therapies across metabolic diseases, chronic care, and beyond.

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

Oryl Photonics has developed a groundbreaking laboratory instrument for solubility and aggregation measurement. It is the world's first accurate and rapid solubility testing solution that saves precious drug compounds.

MedScienceSwiss AG is developing the technology of the future for the treatment of resistant bacteria and has the potential to significantly reduce the number of deaths in hospitals due to nosocomial infections and save resources and money, payers & Nat. Health services. Visit our poster Nr 25 at the Swis

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.

iCure offers the Cardinal platform for developing digital health applications that comply with cybersecurity standards, with end-to-end encryption, FHIR interoperability, and open-source SDKs, accelerating innovation in e-health. iCure is ISO27001,ISO13485,HDS certified and GDPR and NIS2 compliant.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

LabForce AG is a Swiss company, founded in January 1999. We have the largest portfolio of antibodies, proteins and assay kits in Switzerland accomplished by innovative and best in class laboratory equipment in the field of cellular and molecular biology.

inSEIT solves the challenges of enzyme immobilization and unlocks the potential of immobilized biocatalysts for the production of APIs and chemical intermediates. We use bioinformatic tools to reduce the risk, time and cost associated with biocatalyst development.

Delta Medical, based in Zurich, specializes in pharmaceutical marketing, distribution, regulatory affairs, market access, and pharmacovigilance, serving Ukraine and Eurasian markets with tailored commercialization solutions and strategic partnerships.

NexMR offers the first technological solutions to do drug discovery on a benchtop NMR spectrometer without compromising speed and data quality.

At Navignostics we characterize tumors using spatial single-cell proteomics. We use unique capabilities to identify a cancer treatment that will optimally fight a tumor. We accelerate cancer drug development by providing key insights into drug mechanisms and tumor features to pharma companies.

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

Praed Pharmaceuticals is biopharmaceutical company founded by industry experts. Our mission is to deliver a next generation treatment for Crohn’s disease. We are developing a promising oral compound, cadazolid, for the treatment of Crohn’s disease.

Lucerna Chem is one of the leading distributors for life science products in Switzerland, providing high quality reagents and kits from more than 70 suppliers for both research and diagnostics. We conveniently supply our customers with a variety of 4 Mio. products in simple domestic shipments.

Limula is a Life Science Tools company based in Lausanne, Switzerland. We combine cell therapy process development and precision engineering to offer a fully closed and automated platform for the production of CAR-T and other highly-personalised treatments.

Athebio develops ultra-stable biotherapeutics using proprietary Athebody® DARPin molecules with high affinity and specificity. We partner on radiotherapeutics, T cell engagers, targeted delivery (LNP/AAV/oligo) and affinity ligands, enabling breakthrough therapeutic strategies.

Santersus AG is an innovative Therapeutic Apheresis company focused on using our patented technology for the cleansing of patient blood of cell free DNA and neutrophil extracellular traps (NETs) looking to revolutionize how we can control the human immune and inflammatory response to disease.

At Alithea Genomics we develop, produce and commercialize cutting-edge solutions for drug and biomarker discovery based on gene expression. Our products provide high throughput and cost-efficiency, which is ideal for large-scale projects such as drug screening and biomarker discovery.

Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.

MUVON is a Swiss, clinical stage biotech company with the goal of revolutionizing the treatment of diseases caused by muscle damage or degradation through the use of the patients' own cells. Our initial area of focus is the treatment of stress urinary incontinence in women (PhII completed)

Ceidos is a Swiss biotech company developing the C-Netics, an innovative device for automated cell culture monitoring. Their mission is to optimize bioproduction processes for modern treatments through automation and innovative technologies.

OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections, also active in the treatment of vascular diseases.

Sferalp is specialized in the formulation of Self Emulsifying Oils (SEFO) containing extracts or API. SEFO maximize gastro-intestinal absorption. We have developed a SEFO based on natural food components (Patent pending). We provide development in the field of electro- and conventional spray drying.

Cerdia, headquartered in Basel, is a pioneer in cellulose acetate tow since 1912 and a global quality and innovation leader of filter tow for cigarette manufacture. We are developing innovative applications and processes that will define Cellulose Acetate as a sustainable raw material in the future.

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

Clinical-stage biotech company developing next-generation allosteric therapies. Its candidate, GT-02287, is in P1b trials for PD with potential in other neurodegenerative and lysosomal storage disorders. The pipeline also includes preclinical programs targeting metabolic diseases and solid tumors.

Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.

abc biopply AG is pioneering NAM technologies and organoid CRO services that boost in vitro studies for drug discovery and development to IND relevance using its proprietary 3D CoSeedis Multi-Organoid in chip Technology™ on clinically relevant disease models (oncology, neurology, obesity and others)

There is a new kit on the block. Swiss start-up NEMIS Technologies AG specialises in the development of simple, safe, and on-site pathogen testing solutions. Its detection test for Listeria monocytogenes is already commercially available in Switzerland, France, and Spain.

SEED Biosciences is an award-winning company and an enabler of personalized medicine. We provide scientists with innovative single cell tools that are gentle with cells, affordable, intuitive and compliant with stringent regulatory demands.

Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It en

PeptART manufactures a large variety of amino acid derivatives, pseudoprolines, and peptides on-site in our facility in Switzerland. We deliver our products from a few grams up to several tens of kg worldwide. Trust builds on quality and expertise – PeptART – Your Swiss pARTner in Peptide Chemistry.

Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes.

LubioScience is the biggest lifescience reagents & services platform in Switzerland. Representing some of the world’s most recognized brands, we provide over 5 million products from more than 120 suppliers and pride ourselves in working with most Swiss biotech companies & start-ups.

Life Technologies Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community.

Laves-Arzneimittel GmbH has focused on the exploration and development of preparations based on the probiotic Escherichia coli strain Laves discovered in 1931 by Dr. Wolfgang Laves.

Based on the liposomal technology platform, InnoMedica has built a diversified pipeline with lead compounds in oncology and neurodegenerative diseases. Clinical trials for the treatment of breast cancer as well as Parkinson's disease are conducted in Swiss hospitals.

ImmunOs Therapeutics AG is a biotechnology company focused on discovering and developing novel human immunomodulatory proteins for cancer with a specific role in innate immunity.

CSL (ASX:CSL; USOTC:CSLLY) – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

At BD, we are committed to sustainable healthcare. We are inspired by childhood to be innovative thinkers, to be ambitious in our ways of caring about the patients and healthcare professionals of tomorrow.

Amphasys is a leading provider of label-free cell analysis solutions for cells from 1 to 250 um. Characteristics such as size, count and morphology, viability, metabolic and health status are determined real-time. Amphasys is market leader in pollen analysis in the seed industry.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Swiss health science co. pioneering clinically proven products to promote cellular health and longevity. The company’s proprietary nutrient, Mitopure, is clinically shown to combat age-related declines in mitochondrial health and muscle function. Nestlé Health Science is a global strategic partner.